APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dulaglutide Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dulaglutide Injection Market Analysis and Forecast 2026-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchDulaglutide Injection Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Dulaglutide Injection Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Dulaglutide Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dulaglutide Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dulaglutide Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Dulaglutide Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dulaglutide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dulaglutide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dulaglutide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dulaglutide Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dulaglutide Injection include Eli Lilly and Company and Boan Biotech etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dulaglutide Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dulaglutide Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Dulaglutide Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dulaglutide Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dulaglutide Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dulaglutide Injection sales, projected growth trends, production technology, application and end-user industry.

Dulaglutide Injection Segment by Company

Eli Lilly and Company

Boan Biotech

Dulaglutide Injection Segment by Type

0.75 mg/0.5 mL

1.5 mg/0.5 mL

3 mg/0.5 mL

4.5 mg/0.5 mL

Dulaglutide Injection Segment by Application

Adults

Children

Dulaglutide Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dulaglutide Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dulaglutide Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dulaglutide Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dulaglutide Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dulaglutide Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dulaglutide Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dulaglutide Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.75 mg/0.5 mL Major Manufacturers Table 3. 1.5 mg/0.5 mL Major Manufacturers Table 4. 3 mg/0.5 mL Major Manufacturers Table 5. 4.5 mg/0.5 mL Major Manufacturers Table 6. Global Dulaglutide Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Adults Major Manufacturers Table 8. Children Major Manufacturers Table 9. Dulaglutide Injection Industry Trends Table 10. Dulaglutide Injection Industry Drivers Table 11. Dulaglutide Injection Industry Opportunities and Challenges Table 12. Dulaglutide Injection Industry Restraints Table 13. Global Dulaglutide Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Dulaglutide Injection Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Dulaglutide Injection Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Dulaglutide Injection Revenue Market Share by Region (2021-2026) Table 17. Global Dulaglutide Injection Revenue Market Share by Region (2027-2032) Table 18. Global Dulaglutide Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Dulaglutide Injection Sales by Region (2021-2026) & (K Units) Table 20. Global Dulaglutide Injection Sales by Region (2027-2032) & (K Units) Table 21. Global Dulaglutide Injection Sales Market Share by Region (2021-2026) Table 22. Global Dulaglutide Injection Sales Market Share by Region (2027-2032) Table 23. Global Dulaglutide Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Dulaglutide Injection Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Dulaglutide Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Dulaglutide Injection Sales Market Share by Manufacturers (2021-2026) Table 27. Global Dulaglutide Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Dulaglutide Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Dulaglutide Injection Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Dulaglutide Injection Manufacturers, Product Type & Application Table 31. Global Dulaglutide Injection Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Dulaglutide Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Dulaglutide Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Dulaglutide Injection Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Dulaglutide Injection Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Dulaglutide Injection Revenue Market Share by Type (2021-2026) Table 38. Global Dulaglutide Injection Revenue Market Share by Type (2027-2032) Table 39. Global Dulaglutide Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 41. Global Dulaglutide Injection Sales by Type (2027-2032) & (K Units) Table 42. Global Dulaglutide Injection Sales Market Share by Type (2021-2026) Table 43. Global Dulaglutide Injection Sales Market Share by Type (2027-2032) Table 44. Global Dulaglutide Injection Price by Type (2021-2026) & (US$/Unit) Table 45. Global Dulaglutide Injection Price by Type (2027-2032) & (US$/Unit) Table 46. Global Dulaglutide Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Dulaglutide Injection Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Dulaglutide Injection Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Dulaglutide Injection Revenue Market Share by Application (2021-2026) Table 50. Global Dulaglutide Injection Revenue Market Share by Application (2027-2032) Table 51. Global Dulaglutide Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Dulaglutide Injection Sales by Application (2027-2032) & (K Units) Table 54. Global Dulaglutide Injection Sales Market Share by Application (2021-2026) Table 55. Global Dulaglutide Injection Sales Market Share by Application (2027-2032) Table 56. Global Dulaglutide Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Dulaglutide Injection Price by Application (2027-2032) & (US$/Unit) Table 58. Eli Lilly and Company Company Information Table 59. Eli Lilly and Company Business Overview Table 60. Eli Lilly and Company Dulaglutide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Eli Lilly and Company Dulaglutide Injection Product Portfolio Table 62. Eli Lilly and Company Recent Development Table 63. Boan Biotech Company Information Table 64. Boan Biotech Business Overview Table 65. Boan Biotech Dulaglutide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Boan Biotech Dulaglutide Injection Product Portfolio Table 67. Boan Biotech Recent Development Table 68. North America Dulaglutide Injection Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Dulaglutide Injection Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 71. North America Dulaglutide Injection Sales by Type (2027-2032) & (K Units) Table 72. North America Dulaglutide Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 73. North America Dulaglutide Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 74. North America Dulaglutide Injection Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Dulaglutide Injection Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 77. North America Dulaglutide Injection Sales by Application (2027-2032) & (K Units) Table 78. North America Dulaglutide Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 79. North America Dulaglutide Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 80. North America Dulaglutide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Dulaglutide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Dulaglutide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Dulaglutide Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 84. North America Dulaglutide Injection Sales by Country (2021-2026) & (K Units) Table 85. North America Dulaglutide Injection Sales by Country (2027-2032) & (K Units) Table 86. North America Dulaglutide Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 87. North America Dulaglutide Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 88. United States Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 89. Canada Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 90. Mexico Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 91. Europe Dulaglutide Injection Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Dulaglutide Injection Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 94. Europe Dulaglutide Injection Sales by Type (2027-2032) & (K Units) Table 95. Europe Dulaglutide Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 96. Europe Dulaglutide Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 97. Europe Dulaglutide Injection Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Dulaglutide Injection Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 100. Europe Dulaglutide Injection Sales by Application (2027-2032) & (K Units) Table 101. Europe Dulaglutide Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 102. Europe Dulaglutide Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 103. Europe Dulaglutide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Dulaglutide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Dulaglutide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Dulaglutide Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 107. Europe Dulaglutide Injection Sales by Country (2021-2026) & (K Units) Table 108. Europe Dulaglutide Injection Sales by Country (2027-2032) & (K Units) Table 109. Europe Dulaglutide Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 110. Europe Dulaglutide Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 111. Germany Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 112. France Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 113. U.K. Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 114. Italy Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 115. Russia Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 116. Spain Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 119. Sweden Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 120. Poland Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 121. China Dulaglutide Injection Revenue by Type (2021-2026) & (US$ Million) Table 122. China Dulaglutide Injection Revenue by Type (2027-2032) & (US$ Million) Table 123. China Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 124. China Dulaglutide Injection Sales by Type (2027-2032) & (K Units) Table 125. China Dulaglutide Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 126. China Dulaglutide Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 127. China Dulaglutide Injection Revenue by Application (2021-2026) & (US$ Million) Table 128. China Dulaglutide Injection Revenue by Application (2027-2032) & (US$ Million) Table 129. China Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 130. China Dulaglutide Injection Sales by Application (2027-2032) & (K Units) Table 131. China Dulaglutide Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 132. China Dulaglutide Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Asia Dulaglutide Injection Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Dulaglutide Injection Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 136. Asia Dulaglutide Injection Sales by Type (2027-2032) & (K Units) Table 137. Asia Dulaglutide Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 138. Asia Dulaglutide Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 139. Asia Dulaglutide Injection Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Dulaglutide Injection Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 142. Asia Dulaglutide Injection Sales by Application (2027-2032) & (K Units) Table 143. Asia Dulaglutide Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 144. Asia Dulaglutide Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Asia Dulaglutide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Dulaglutide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Dulaglutide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Dulaglutide Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. Asia Dulaglutide Injection Sales by Country (2021-2026) & (K Units) Table 150. Asia Dulaglutide Injection Sales by Country (2027-2032) & (K Units) Table 151. Asia Dulaglutide Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 152. Asia Dulaglutide Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 153. Japan Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 154. South Korea Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 155. India Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 156. Australia Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Dulaglutide Injection Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Dulaglutide Injection Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Dulaglutide Injection Sales by Type (2021-2026) & (K Units) Table 162. SAMEA Dulaglutide Injection Sales by Type (2027-2032) & (K Units) Table 163. SAMEA Dulaglutide Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 164. SAMEA Dulaglutide Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 165. SAMEA Dulaglutide Injection Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Dulaglutide Injection Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Dulaglutide Injection Sales by Application (2021-2026) & (K Units) Table 168. SAMEA Dulaglutide Injection Sales by Application (2027-2032) & (K Units) Table 169. SAMEA Dulaglutide Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 170. SAMEA Dulaglutide Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 171. SAMEA Dulaglutide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Dulaglutide Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Dulaglutide Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Dulaglutide Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. SAMEA Dulaglutide Injection Sales by Country (2021-2026) & (K Units) Table 176. SAMEA Dulaglutide Injection Sales by Country (2027-2032) & (K Units) Table 177. SAMEA Dulaglutide Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 178. SAMEA Dulaglutide Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Brazil Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 180. Argentina Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 181. Chile Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 182. Colombia Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 183. Peru Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 185. Israel Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 186. UAE Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 187. Turkey Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 188. Iran Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 189. Egypt Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Dulaglutide Injection Distributors List Table 193. Dulaglutide Injection Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Dulaglutide Injection Image Figure 2. Global Dulaglutide Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dulaglutide Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.75 mg/0.5 mL Image Figure 5. 1.5 mg/0.5 mL Image Figure 6. 3 mg/0.5 mL Image Figure 7. 4.5 mg/0.5 mL Image Figure 8. Global Dulaglutide Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Dulaglutide Injection Market Size Share 2021 VS 2025 VS 2032 Figure 10. Adults Image Figure 11. Children Image Figure 12. Global Dulaglutide Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Dulaglutide Injection Revenue (2021-2032) & (US$ Million) Figure 14. Global Dulaglutide Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Dulaglutide Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Dulaglutide Injection Revenue Market Share by Region (2021-2032) Figure 17. Global Dulaglutide Injection Sales (2021-2032) & (K Units) Figure 18. Global Dulaglutide Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Dulaglutide Injection Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Dulaglutide Injection Sales YoY (2021-2032) & (K Units) Figure 21. Europe Dulaglutide Injection Sales YoY (2021-2032) & (K Units) Figure 22. China Dulaglutide Injection Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Dulaglutide Injection Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Dulaglutide Injection Sales YoY (2021-2032) & (K Units) Figure 25. Global Dulaglutide Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Dulaglutide Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Dulaglutide Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Dulaglutide Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Dulaglutide Injection Revenue Market Share by Type (2021-2032) Figure 31. Global Dulaglutide Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Dulaglutide Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Dulaglutide Injection Sales Market Share by Type (2021-2032) Figure 34. Global Dulaglutide Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Dulaglutide Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Dulaglutide Injection Revenue Market Share by Application (2021-2032) Figure 37. Global Dulaglutide Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Dulaglutide Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Dulaglutide Injection Sales Market Share by Application (2021-2032) Figure 40. North America Dulaglutide Injection Revenue Share by Type (2021-2032) Figure 41. North America Dulaglutide Injection Sales Share by Type (2021-2032) Figure 42. North America Dulaglutide Injection Revenue Share by Application (2021-2032) Figure 43. North America Dulaglutide Injection Sales Share by Application (2021-2032) Figure 44. North America Dulaglutide Injection Revenue Share by Country (2021-2032) Figure 45. North America Dulaglutide Injection Sales Share by Country (2021-2032) Figure 46. Europe Dulaglutide Injection Revenue Share by Type (2021-2032) Figure 47. Europe Dulaglutide Injection Sales Share by Type (2021-2032) Figure 48. Europe Dulaglutide Injection Revenue Share by Application (2021-2032) Figure 49. Europe Dulaglutide Injection Sales Share by Application (2021-2032) Figure 50. Europe Dulaglutide Injection Revenue Share by Country (2021-2032) Figure 51. Europe Dulaglutide Injection Sales Share by Country (2021-2032) Figure 52. China Dulaglutide Injection Revenue Share by Type (2021-2032) Figure 53. China Dulaglutide Injection Sales Share by Type (2021-2032) Figure 54. China Dulaglutide Injection Revenue Share by Application (2021-2032) Figure 55. China Dulaglutide Injection Sales Share by Application (2021-2032) Figure 56. Asia Dulaglutide Injection Revenue Share by Type (2021-2032) Figure 57. Asia Dulaglutide Injection Sales Share by Type (2021-2032) Figure 58. Asia Dulaglutide Injection Revenue Share by Application (2021-2032) Figure 59. Asia Dulaglutide Injection Sales Share by Application (2021-2032) Figure 60. Asia Dulaglutide Injection Revenue Share by Country (2021-2032) Figure 61. Asia Dulaglutide Injection Sales Share by Country (2021-2032) Figure 62. SAMEA Dulaglutide Injection Revenue Share by Type (2021-2032) Figure 63. SAMEA Dulaglutide Injection Sales Share by Type (2021-2032) Figure 64. SAMEA Dulaglutide Injection Revenue Share by Application (2021-2032) Figure 65. SAMEA Dulaglutide Injection Sales Share by Application (2021-2032) Figure 66. SAMEA Dulaglutide Injection Revenue Share by Country (2021-2032) Figure 67. SAMEA Dulaglutide Injection Sales Share by Country (2021-2032) Figure 68. Dulaglutide Injection Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Dulaglutide Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 0.75 mg/0.5 mL
  • 1.5 mg/0.5 mL
  • 3 mg/0.5 mL
  • 4.5 mg/0.5 mL
Applications
  • Adults
  • Children
Companies covered
  • Eli Lilly and Company
  • Boan Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dulaglutide Injection Market by Type
  3. 1.2.1 Global Dulaglutide Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.75 mg/0.5 mL
  5. 1.2.3 1.5 mg/0.5 mL
  6. 1.2.4 3 mg/0.5 mL
  7. 1.2.5 4.5 mg/0.5 mL
  8. 1.3 Dulaglutide Injection Market by Application
  9. 1.3.1 Global Dulaglutide Injection Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Adults
  11. 1.3.3 Children
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Dulaglutide Injection Market Dynamics
  1. 2.1 Dulaglutide Injection Industry Trends
  2. 2.2 Dulaglutide Injection Industry Drivers
  3. 2.3 Dulaglutide Injection Industry Opportunities and Challenges
  4. 2.4 Dulaglutide Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dulaglutide Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dulaglutide Injection Revenue by Region
  3. 3.2.1 Global Dulaglutide Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dulaglutide Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Dulaglutide Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Dulaglutide Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dulaglutide Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dulaglutide Injection Sales by Region
  9. 3.4.1 Global Dulaglutide Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dulaglutide Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Dulaglutide Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Dulaglutide Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dulaglutide Injection Revenue by Manufacturers
  2. 4.1.1 Global Dulaglutide Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dulaglutide Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dulaglutide Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dulaglutide Injection Sales by Manufacturers
  6. 4.2.1 Global Dulaglutide Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dulaglutide Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dulaglutide Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dulaglutide Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dulaglutide Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dulaglutide Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dulaglutide Injection Manufacturers, Product Type & Application
  13. 4.7 Global Dulaglutide Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dulaglutide Injection Market CR5 and HHI
  16. 4.8.2 2025 Dulaglutide Injection Tier 1, Tier 2, and Tier 3
5 Dulaglutide Injection Market by Type
  1. 5.1 Global Dulaglutide Injection Revenue by Type
  2. 5.1.1 Global Dulaglutide Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dulaglutide Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dulaglutide Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dulaglutide Injection Sales by Type
  6. 5.2.1 Global Dulaglutide Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dulaglutide Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dulaglutide Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dulaglutide Injection Price by Type
6 Dulaglutide Injection Market by Application
  1. 6.1 Global Dulaglutide Injection Revenue by Application
  2. 6.1.1 Global Dulaglutide Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dulaglutide Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dulaglutide Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dulaglutide Injection Sales by Application
  6. 6.2.1 Global Dulaglutide Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dulaglutide Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dulaglutide Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dulaglutide Injection Price by Application
7 Company Profiles
  1. 7.1 Eli Lilly and Company
  2. 7.1.1 Eli Lilly and Company Company Information
  3. 7.1.2 Eli Lilly and Company Business Overview
  4. 7.1.3 Eli Lilly and Company Dulaglutide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eli Lilly and Company Dulaglutide Injection Product Portfolio
  6. 7.1.5 Eli Lilly and Company Recent Developments
  7. 7.2 Boan Biotech
  8. 7.2.1 Boan Biotech Company Information
  9. 7.2.2 Boan Biotech Business Overview
  10. 7.2.3 Boan Biotech Dulaglutide Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Boan Biotech Dulaglutide Injection Product Portfolio
  12. 7.2.5 Boan Biotech Recent Developments
8 North America
  1. 8.1 North America Dulaglutide Injection Market Size by Type
  2. 8.1.1 North America Dulaglutide Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Dulaglutide Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Dulaglutide Injection Price by Type (2021-2032)
  5. 8.2 North America Dulaglutide Injection Market Size by Application
  6. 8.2.1 North America Dulaglutide Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Dulaglutide Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Dulaglutide Injection Price by Application (2021-2032)
  9. 8.3 North America Dulaglutide Injection Market Size by Country
  10. 8.3.1 North America Dulaglutide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dulaglutide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dulaglutide Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dulaglutide Injection Market Size by Type
  2. 9.1.1 Europe Dulaglutide Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dulaglutide Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Dulaglutide Injection Price by Type (2021-2032)
  5. 9.2 Europe Dulaglutide Injection Market Size by Application
  6. 9.2.1 Europe Dulaglutide Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dulaglutide Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Dulaglutide Injection Price by Application (2021-2032)
  9. 9.3 Europe Dulaglutide Injection Market Size by Country
  10. 9.3.1 Europe Dulaglutide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dulaglutide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dulaglutide Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dulaglutide Injection Market Size by Type
  2. 10.1.1 China Dulaglutide Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Dulaglutide Injection Sales by Type (2021-2032)
  4. 10.1.3 China Dulaglutide Injection Price by Type (2021-2032)
  5. 10.2 China Dulaglutide Injection Market Size by Application
  6. 10.2.1 China Dulaglutide Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Dulaglutide Injection Sales by Application (2021-2032)
  8. 10.2.3 China Dulaglutide Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dulaglutide Injection Market Size by Type
  2. 11.1.1 Asia Dulaglutide Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dulaglutide Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Dulaglutide Injection Price by Type (2021-2032)
  5. 11.2 Asia Dulaglutide Injection Market Size by Application
  6. 11.2.1 Asia Dulaglutide Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dulaglutide Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Dulaglutide Injection Price by Application (2021-2032)
  9. 11.3 Asia Dulaglutide Injection Market Size by Country
  10. 11.3.1 Asia Dulaglutide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dulaglutide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dulaglutide Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dulaglutide Injection Market Size by Type
  2. 12.1.1 SAMEA Dulaglutide Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dulaglutide Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dulaglutide Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Dulaglutide Injection Market Size by Application
  6. 12.2.1 SAMEA Dulaglutide Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dulaglutide Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dulaglutide Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Dulaglutide Injection Market Size by Country
  10. 12.3.1 SAMEA Dulaglutide Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dulaglutide Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dulaglutide Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dulaglutide Injection Value Chain Analysis
  2. 13.1.1 Dulaglutide Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dulaglutide Injection Production Mode & Process
  6. 13.2 Dulaglutide Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dulaglutide Injection Distributors
  9. 13.2.3 Dulaglutide Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst